Your browser doesn't support javascript.
loading
Effect of abciximab on angiographic complications during percutaneous coronary stenting in the Evaluation of Platelet IIb/IIIa Inhibition in Stenting Trial (EPISTENT).
Islam, M Ashequl; Blankenship, James C; Balog, Craig; Iliadis, Elias A; Lincoff, A Michael; Tcheng, James E; Califf, Robert M; Topol, Eric J.
Affiliation
  • Islam MA; Geisinger Medical Center, Danville, Pennsylvania 17822, USA.
Am J Cardiol ; 90(9): 916-21, 2002 Nov 01.
Article in En | MEDLINE | ID: mdl-12398954
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Immunoglobulin Fab Fragments / Platelet Aggregation Inhibitors / Angioplasty, Balloon, Coronary / Stents / Coronary Angiography / Platelet Glycoprotein GPIIb-IIIa Complex / Antibodies, Monoclonal Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Prognostic_studies Limits: Female / Humans / Male Country/Region as subject: America do norte Language: En Journal: Am J Cardiol Year: 2002 Document type: Article Affiliation country: United States
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Immunoglobulin Fab Fragments / Platelet Aggregation Inhibitors / Angioplasty, Balloon, Coronary / Stents / Coronary Angiography / Platelet Glycoprotein GPIIb-IIIa Complex / Antibodies, Monoclonal Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Prognostic_studies Limits: Female / Humans / Male Country/Region as subject: America do norte Language: En Journal: Am J Cardiol Year: 2002 Document type: Article Affiliation country: United States